Companies planning IPOs are scrambling to navigate market volatility triggered by Middle East tensions, with some deals accelerating while others pause. Vincorion, a European defense technology firm supplying Raytheon's Patriot missile system, is pushing forward with its Frankfurt IPO this week, potentially accelerating its timetable as geopolitical risks boost defense sector appeal.

MiniMed Group Inc., Medtronic's diabetes device unit, remains on track for a Thursday pricing despite market jitters, with its offering already oversubscribed. The conflict threatens to derail what was shaping up as a strong IPO year, echoing last year's market freeze following Trump's tariff announcement. Investment bankers report investors are digesting weekend events while hoping tensions don't escalate further.

Defense contractors appear insulated from the volatility, with CSG NV's January Amsterdam IPO demonstrating how fixed-price deals and cornerstone investors can weather geopolitical storms. However, the broader IPO window has effectively closed for most companies, according to industry experts. With recent listings underperforming and software stocks in selloff mode, bankers warn that prolonged Middle East hostilities could sideline IPO activity for months, potentially derailing the recovery momentum building since 2022.